News
MAMMOTOME NEWS
Mammotome Initiatives to Reduce Our Environmental Footprint
In addition to improving breast care for patients worldwide, Mammotome is on a mission to reduce its environmental impact. Continue reading to learn about several
Nuvance Health offers breast cancer surgical technique that reduces side effects from surgery
“We can now greatly reduce a patient’s risk of developing lymphedema after a mastectomy to treat DCIS because we do not need to remove lymph
The Magtrace® lymphatic tracer offers a new option for assessing DCIS
“…While DCIS may not be viewed as life or death for patients, having techniques that prevent complications down the road are beneficial and important for
Baptist Health now offering the Magseed® magnetic marker for breast cancer patients
Photo by Kelly Farrell / The Paducah Sun “What I tell my patients is (that) when I use Magseed, it decreases their anxiety. It decreases
PRESS RELEASES
Mammotome Launches the LumiMARK™ Biopsy Site Marker, a Tissue Marker Distinct from Every Angle
Mammotome announced the 510(k) clearance for the novel LumiMARK™ Biopsy Site Marker, a tissue marker line designed with visibility top of mind.
Mammotome Launches the HydroMARK™ Plus Breast Biopsy Site Marker, an Innovation for Tissue Marker Displacement
Mammotome announced the launch of an innovative new HydroMARKTM Plus Breast Biopsy Site Marker designed to enhance ultrasound visibility, improve ease
Mammotome Announces the Launch of the Mammotome DualCore™ Dual Stage Core Biopsy System
Mammotome Announces the Launch of the Mammotome DualCore™ Dual Stage Core Biopsy System CINCINNATI, OHIO – August 25, 2022 – Mammotome is excited to announce
New product line extension for the HydroMARK™ breast biopsy site markers
Devicor Medical Products, Inc. (Mammotome) Announces a New Product Line Extension for the HydroMARK™ Breast Biopsy Site Markers CINCINNATI, OHIO – April 14, 2021 –